Theoretical analysis of drug treatment in haematological disease using Lanchester (Osipov) linear law

Comparative Clinical Pathology

Volumn 11, Issue 2, 2002, Pages 113-118

  Wu, G ^a   Yan, S M ^b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Haematological diseases; Lanchester (Osipov) equations

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL COUNT; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG HALF LIFE; HEMATOLOGIC DISEASE; IN VIVO STUDY; LINEAR SYSTEM; MATHEMATICAL COMPUTING; SIMULATION;

EID: 0036555249     PISSN: 16185641     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005800200008     Document Type: Article

References (10)

1. Helmbold RL (1993) Osipov: The 'Russian Lanchester'. Eur J Ope Res 65:278-278
2. Iliadis A, Barbolosi D (2000) Optimizing drug regimens in cancer chemotherapy by an efficacy-toxicity mathematical model. Comput Biomed Res 33:211-226
3. Karlsson MO, Port RE, Ratain MJ, et al. (1995) A population model for the leukopenic effect of etoposide. Clin Pharmacol Ther 57:325-334
4. Lockhart RD (1967) Dr. Frederick W. Lanchester (1868-1946) Fellow of the Royal Society, engineer, scientist, inventor. Ala J Med Sci 4:354-359
5. Osipov M (1995) The influence of the numerical strength of engaged forces in their casualties. Translated by Helmbold RL and Rehm AS. Naval Res Logistics 42:435-490
6. Wu G, Furlanut M (1996) Prediction of blood cyclosporine concentrations in haematological patients with multidrug resistance by means of total, lean and different adipose dosing body weight using Bayesian and non-linear least squares methods. Int J Clin Pharmacol Res 16:89-97
7. Wu G, Furlanut M (1999) Prediction of blood cyclosporine concentrations in non-obese and obese hematologic patients with multidrug resistance by total, lean and different adipose dosing body weights. Haematologica 84:476-477
8. Wu G, Baraldo M, Pea F, Cossettini P, Furlanut M (1995) Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods. Pharmacol Res 32:355-362
9. Wu G, Cossettini P, Furlanut M (1996) Prediction of blood cyclosporine concentrations in haematological patients with multidrug resistance by one-, two- and three-compartment models using Bayesian and nonlinear least squares methods. Pharmacol Res 34:47-57
10. Wu G, Pea F, Cossettini P, Furlanut M (1998) Effect of the number of samples on Bayesian and non-linear least-squares individualization: a study of cyclosporin treatment of haematological patients with multidrug resistance. J Pharm Pharmacol 50:343-349